Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors
Clinical trial NCT02379416 · COMPLETED
Trial details
- NCT number
- NCT02379416
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-13
- Primary completion
- 2025-04-30
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.